BCAA / Branched-Chain Amino Acids for Exercise Recovery

Verdict: Modest, inconsistent benefit for soreness

BCAA supplements may modestly reduce muscle soreness and some damage markers after hard exercise, but the effect is inconsistent and likely small once you already eat enough protein. They do not meaningfully speed up actual recovery of muscle performance, so the evidence is rated weak.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

Four meta-analyses and overviews of systematic reviews drive the weak (C) grade, and they disagree. A 2024 meta-analysis (PMID 38625669) found large reductions in delayed-onset soreness (Hedges g around -1.75 at 48h) and lower creatine kinase, and a 2024 overview of reviews (PMID 38241335) reported medium effects on CK and small-to-large effects on soreness. But the older 2017 meta-analysis (PMID 28870476) found CK reduced yet soreness and LDH unchanged, and a 2021 meta-analysis (PMID 34669012) saw benefit in only 7 of 10 trials with high between-study variability.

Two limitations cap the grade. Most trials never controlled participants' baseline protein intake, so the apparent benefit may simply reflect topping up an inadequate diet rather than a special BCAA effect. And across reviews there was consistently no improvement in LDH, myoglobin, or actual muscle-performance recovery (PMID 38241335) — the measured wins are mostly surrogate markers. The supporting single RCT (PMID 33539692) had just 12 people.

Authorities are split, which matches a weak verdict. The US FDA treats BCAAs only as a GRAS nutrient supplement and approves no efficacy claim, while EU EFSA formally rejected all BCAA recovery and fatigue claims in 2010 for lack of established cause and effect. NIH ODS and a relevant specialty society are cautious, Cleveland Clinic is mildly supportive, and the WHO and UK NHS take no position on supplementation. Bottom line: possible small help with soreness, but no reliable recovery boost, especially if protein intake is already adequate.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.51
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
75%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.58
L1 ExamineGlobal benchmark
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.512
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 1 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with BCAA Supplementati
PMID: 38625669 2024 統合分析
Finding: DOMS significantly reduced at 24h (g=-1.34), 48h (g=-1.75), 72h (g=-1.82), 96h (g=-0.82); CK reduced at 0h (g=-0.44, p=0.006) and 72h (g=-0.99, p=0.002); LDH not significant.
Effect size: Hedges g: DOMS 48h = -1.75; CK 72h = -0.99
View on PubMed
Branched-Chain Amino Acids Supplementation and Post-Exercise Recovery: An Overview of Systematic Reviews
PMID: 38241335 2024 系統性回顧
Finding: BCAA attenuates CK (medium effects) and soreness (small-to-large effects) post-EIMD; no effect on LDH, myoglobin, or muscle performance recovery.
Effect size: trivial-to-large for CK; small-to-large for soreness (narrative range across 11 SRs)
View on PubMed
The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: a systematic review and meta-an
PMID: 34669012 2021 統合分析
Finding: 7/10 RCTs showed BCAA reduced DOMS within 24-72h; benefits clearest in trained subjects at low doses with mild-to-moderate EIMD; high inter-study variability limits firm conclusions.
Government Effect size: null
View on PubMed
Branched-chain amino acid supplementation and exercise-induced muscle damage in exercise recovery: A meta-analysis of ran
PMID: 28870476 2017 統合分析
Finding: BCAA significantly reduced CK at <24h (MD -71.55 U/L, p<0.001) and 24h (MD -145.04 U/L, p=0.009); DOMS and LDH not significant at any timepoint.
Effect size: MD CK at 24h: -145.04 U/L
View on PubMed
Effects of branched-chain amino acid supplement on knee peak torque and indicators of muscle damage following isokinetic e
PMID: 33539692 2020 RCT (double-blind) n = 12
Finding: CK and LDH significantly reduced in BCAA vs placebo; extension peak torque higher at D3 (p<0.05); no difference in AST or flexion torque.
🟠 Limited quality Academic Effect size: null
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
NUTRIENT SUPPLEMENT source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
L-白胺酸(L-Leucine,編號095)、L-異白胺酸(L-Isoleucine,編號048)、L-纈胺酸(L-α胺基異戊酸/L-Valine,編號051)均列於「食品添加物使用範圍及限量暨規格標準」附表一第(八)類營養添加劑,使用食品範圍及限量:各類食品中視實際需要適量使用(以補充食品中不足之營養素為目的)。 source↗
L4e WHO
Not addressed
WHO/FAO/UNU Technical Report Series 935 (2007): Indispensable amino acid requirements for adults — leucine 39 mg/kg/day, isoleucine 20 mg/kg/day, valine 26 mg/kg/day (derived from 24-hour 13C leucine balance studies and body protein amino acid composition). source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Supportive
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-recovery-INT-branched-chain-amino-acids-001 繁體中文版 →